Rare diseases
Investigational molecules
Locations
Back to Germany143 clinical trials in Dortmund, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ICP-332 for Adults with Prurigo Nodularis
GermanyComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
GermanyEffect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury
GermanyStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
GermanyA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
GermanyStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
GermanyA Study of Tenecteplase for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants
GermanyA Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded
GermanyTesting dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease
GermanyA study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain
GermanyStudy of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma
GermanyStudy evaluating HER2DX-guided treatment in patients with early-stage HER2-positive breast cancer using trastuzumab, pertuzumab and combination chemotherapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on various cancer types, including lymphomas, breast cancer, and hepatic tumors. Studies evaluate novel treatment combinations and personalized approaches.
Innovative protocols combining immunotherapy with conventional treatments to improve patient outcomes.
Extensive research into cardiovascular diseases, focusing on preventive treatments and management of acute conditions. Studies examine new approaches to reduce major cardiac events.
Novel therapies targeting lipid management and cardiovascular risk reduction.
Clinical investigations focusing on multiple sclerosis and other neurological conditions. Studies evaluate new treatment options and disease-modifying therapies.
Research aims to improve patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
